Optimal Supervised Reduction of High Dimensional Transcription Data
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal Supervised Reduction of High Dimensional Transcription Data
Authors
Keywords
-
Journal
IEEE-ACM Transactions on Computational Biology and Bioinformatics
Volume 20, Issue 5, Pages 3093-3105
Publisher
Institute of Electrical and Electronics Engineers (IEEE)
Online
2023-06-06
DOI
10.1109/tcbb.2023.3280557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review of UMAP in population genetics
- (2020) Alex Diaz-Papkovich et al. JOURNAL OF HUMAN GENETICS
- Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling
- (2019) Shawn J. Rice et al. LUNG CANCER
- Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma
- (2019) Yu Liu et al. PeerJ
- Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer
- (2019) Firoz Ahmed Frontiers in Oncology
- SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma
- (2018) Weiguo Zhang et al. Oncology Letters
- A Review of Matched-pairs Feature Selection Methods for Gene Expression Data Analysis
- (2018) Sen Liang et al. Computational and Structural Biotechnology Journal
- Dimensionality reduction for visualizing single-cell data using UMAP
- (2018) Etienne Becht et al. NATURE BIOTECHNOLOGY
- Visualizing and Interpreting Single-Cell Gene Expression Datasets with Similarity Weighted Nonnegative Embedding
- (2018) Yan Wu et al. Cell Systems
- Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer
- (2017) Dan Zhou et al. Oncotarget
- Sparse Fisher's linear discriminant analysis for partially labeled data
- (2017) Qiyi Lu et al. Statistical Analysis and Data Mining
- High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
- (2017) Estela Maria Silva et al. PLoS One
- Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells
- (2017) Hiroyuki Ogawa et al. Scientific Reports
- Principal component analysis for designed experiments
- (2015) Tomokazu Konishi BMC BIOINFORMATICS
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
- (2015) Isaac S. Harris et al. CANCER CELL
- Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer
- (2015) Z. Qu et al. CANCER RESEARCH
- Algorithms and tools for protein–protein interaction networks clustering, with a special focus on population-based stochastic methods
- (2014) Clara Pizzuti et al. BIOINFORMATICS
- The good, the bad, and the ugly of interleukin-6 signaling
- (2014) J. J. Fuster et al. EMBO JOURNAL
- Mutual Information between Discrete and Continuous Data Sets
- (2014) Brian C. Ross PLoS One
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Comparing the dimensionality reduction methods in gene expression databases
- (2012) Helyane Bronoski Borges et al. EXPERT SYSTEMS WITH APPLICATIONS
- Integrating Factor Analysis and a Transgenic Mouse Model to Reveal a Peripheral Blood Predictor of Breast Tumors
- (2011) Heather G LaBreche et al. BMC Medical Genomics
- Identification of a Novel Biomarker, SEMA5A, for Non-Small Cell Lung Carcinoma in Nonsmoking Women
- (2010) T.-P. Lu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic programming for anticancer therapeutic response prediction using the NCI-60 dataset
- (2009) Francesco Archetti et al. COMPUTERS & OPERATIONS RESEARCH
- An efficient approach for building customer profiles from business data
- (2009) L.B. Romdhane et al. EXPERT SYSTEMS WITH APPLICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started